PURE BIOSCIENCE INC COM STK NEW (DE)
PURE
PURE was delisted on the 16th of May, 2013.
1 hedge funds and large institutions have $380K invested in PURE BIOSCIENCE INC COM STK NEW (DE) in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
60% less capital invested
Capital invested by funds: $959K → $380K (-$579K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Goldman Capital Management
New York
|
-$385K |
PURE Hedge Fund Activity: Q4 2016 in Review
1 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in PURE BIOSCIENCE INC COM STK NEW (DE) (PURE) for Q4 2016, worth a combined $380K — down 60% from $959K a quarter earlier.
Fund positioning in PURE was balanced in Q4 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Goldman Capital Management, cutting an estimated $385K.
- 1 institutional investor held PURE BIOSCIENCE INC COM STK NEW (DE) (PURE) as of Q4 2016, down from 2 in Q3 2016.
- Funds reported $380K of PURE BIOSCIENCE INC COM STK NEW (DE) stock for Q4 2016, down 60% quarter-over-quarter.
- 0 funds opened new PURE BIOSCIENCE INC COM STK NEW (DE) positions in Q4 2016 and 0 closed out.
- The largest PURE BIOSCIENCE INC COM STK NEW (DE) seller in Q4 2016 was Goldman Capital Management, an estimated $385K sold.
Based on aggregated 13F filings for Q4 2016.